Peregrine Capital Management LLC Sarepta Therapeutics, Inc. Transaction History
Peregrine Capital Management LLC
- $3.18 Billion
- Q4 2024
A detailed history of Peregrine Capital Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Peregrine Capital Management LLC holds 53,804 shares of SRPT stock, worth $5.54 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
53,804
Previous 41,839
28.6%
Holding current value
$5.54 Million
Previous $5.23 Million
25.21%
% of portfolio
0.21%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.06 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$936 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$896 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$446 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$419 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.02B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...